GlassScriptPhysician profile
Robert J Carangelo
NPI 1063529352
$3,747.70
in general payments reported to CMS, 2019-2025
11 companies · $353 in 2025
The $353 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,625 · 2020: $77.64 · 2021: $122 · 2022: $365 · 2023: $757 · 2024: $448 · 2025: $353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,558.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,558.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,223.35 | 2019-2025 | Persona, Osseoti Reconstructive System, Trabecular Metal |
| Smith+Nephew, INC. | $1,195.40 | 2019-2023 | Pico 14 |
| Stryker Corporation | $850.56 | 2019-2025 | Mako, Triathlon |
| Depuy Synthes Sales INC. | $105.16 | 2021-2024 | Orthovisc, Monovisc, Va-Lcp |
| Vericel Corporation | $83.75 | 2022 | |
| Bioventus LLC | $74.69 | 2022-2023 | Durolane |
| Pacira Therapeutics, INC. | $61.87 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $51.14 | 2021-2025 | Euflexxa |
| Horizon Therapeutics Plc | $43.68 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $33.05 | 2025 | Exparel, Iovera, Zilretta |
| Molnlycke Health Care US, LLC | $25.05 | 2025 | Mepilex Border Post-Op Ag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Carangelo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.